Menu
← Oncology Approval Tracker
FDA DECISION ·
Beizray
docetaxel · Zhuhai Beihai Biotech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Docetaxel injection for labeled settings in breast cancer, non-small cell lung cancer, metastatic castration-resistant prostate cancer, gastric adenocarcinoma and locally advanced head and neck squamous cell carcinoma.
LAMPGEN ANALYSIS
Why it matters
The albumin-containing formulation is a distinct docetaxel presentation for established oncology uses.
What research teams should watch
Maintain separate preparation instructions and verify infusion concentration, corticosteroid premedication and regimen before dispensing.
PRIMARY RECORDS